These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35386737)

  • 1. Interstitial lung disease in systemic sclerosis quantification of disease classification and progression with high-resolution computed tomography: An observational study.
    Clukers J; Lanclus M; Belmans D; Van Holsbeke C; De Backer W; Vummidi D; Cronin P; Lavon BR; De Backer J; Khanna D
    J Scleroderma Relat Disord; 2021 Jun; 6(2):154-164. PubMed ID: 35386737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative computed tomography assessment for systemic sclerosis-related interstitial lung disease: comparison of different methods.
    Ufuk F; Demirci M; Altinisik G
    Eur Radiol; 2020 Aug; 30(8):4369-4380. PubMed ID: 32193641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels.
    Occhipinti M; Bosello S; Sisti LG; Cicchetti G; de Waure C; Pirronti T; Ferraccioli G; Gremese E; Larici AR
    PLoS One; 2019; 14(3):e0213444. PubMed ID: 30861018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tomographic Fibrosis Score in the Patients with Systemic Sclerosis-Associated Interstitial Lung Disease.
    Ozmen M; Gumus C; Otman E; Sinci KA; Aysin IK; Solmaz D; Akar S
    Eur J Rheumatol; 2023 Jul; 10(3):107-113. PubMed ID: 37681257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group.
    Khanna D; Tseng CH; Farmani N; Steen V; Furst DE; Clements PJ; Roth MD; Goldin J; Elashoff R; Seibold JR; Saggar R; Tashkin DP
    Arthritis Rheum; 2011 Oct; 63(10):3078-85. PubMed ID: 21618205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis.
    Hoffmann-Vold AM; Aaløkken TM; Lund MB; Garen T; Midtvedt Ø; Brunborg C; Gran JT; Molberg Ø
    Arthritis Rheumatol; 2015 May; 67(8):2205-12. PubMed ID: 25916462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal change during follow-up of systemic sclerosis: correlation between high-resolution computed tomography and pulmonary function tests.
    Carnevale A; Silva M; Maietti E; Milanese G; Saracco M; Parisi S; Bravi E; De Gennaro F; Arrigoni E; Bodini FC; Fusaro E; Scirè CA; Sverzellati N; Ariani A
    Clin Rheumatol; 2021 Jan; 40(1):213-219. PubMed ID: 32880053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials.
    Khanna D; Nagaraja V; Tseng CH; Abtin F; Suh R; Kim G; Wells A; Furst DE; Clements PJ; Roth MD; Tashkin DP; Goldin J
    Arthritis Res Ther; 2015 Dec; 17():372. PubMed ID: 26704522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension and systemic sclerosis: the role of high-resolution computed tomography.
    Zompatori M; Leone MB; Giannotta M; Galiè N; Palazzini M; Reggiani ML; Bono L; Pollini GS
    Radiol Med; 2013 Dec; 118(8):1360-72. PubMed ID: 23716290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate in scleroderma-associated interstitial lung disease: Real-world data from rheumatology and pulmonology clinics in South Asia.
    Janardana R; Irodi A; Chebbi PP; Goel R; Vimala LR; Padiyar S; Peediyakal A; Mathew J; Nair A; Christopher DJ; Danda D
    J Scleroderma Relat Disord; 2021 Oct; 6(3):271-276. PubMed ID: 35387216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
    Barnes H; Holland AE; Westall GP; Goh NS; Glaspole IN
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010908. PubMed ID: 29297205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational analysis of thoracic multidetector row HRCT for segmentation and quantification of small airway air trapping and emphysema in obstructive pulmonary disease.
    Barbosa EM; Song G; Tustison N; Kreider M; Gee JC; Gefter WB; Torigian DA
    Acad Radiol; 2011 Oct; 18(10):1258-69. PubMed ID: 21893294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Computed Tomography Densitometry with Disease Severity, Functional Decline, and Survival in Systemic Sclerosis-associated Interstitial Lung Disease.
    Saldana DC; Hague CJ; Murphy D; Coxson HO; Tschirren J; Peterson S; Sieren JP; Kirby M; Ryerson CJ
    Ann Am Thorac Soc; 2020 Jul; 17(7):813-820. PubMed ID: 32191491
    [No Abstract]   [Full Text] [Related]  

  • 15. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
    Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
    Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and clinical correlates of small airway obstruction in patients with systemic sclerosis.
    Ostojic P; Vujovic M
    Clin Rheumatol; 2021 Apr; 40(4):1417-1422. PubMed ID: 32827283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentration of surfactant protein D in patients with systemic sclerosis: The potential marker of the interstitial lung disease severity.
    Grosicka A; Manasar A; Kucharz EJ; Kotyla PJ
    Best Pract Res Clin Rheumatol; 2018 Aug; 32(4):541-549. PubMed ID: 31174823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography.
    Khanna D; Distler O; Cottin V; Brown KK; Chung L; Goldin JG; Matteson EL; Kazerooni EA; Walsh SL; McNitt-Gray M; Maher TM
    J Scleroderma Relat Disord; 2022 Oct; 7(3):168-178. PubMed ID: 36211204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease.
    Elhai M; Hoffmann-Vold AM; Avouac J; Pezet S; Cauvet A; Leblond A; Fretheim H; Garen T; Kuwana M; Molberg Ø; Allanore Y
    Arthritis Rheumatol; 2019 Jun; 71(6):972-982. PubMed ID: 30624031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative chest CT analysis in patients with systemic sclerosis before and after autologous stem cell transplantation: comparison of results with those of pulmonary function tests and clinical tests.
    Kloth C; Maximilian Thaiss W; Preibsch H; Mark K; Kötter I; Hetzel J; Nikolaou K; Henes J; Horger M
    Rheumatology (Oxford); 2016 Oct; 55(10):1763-70. PubMed ID: 27330164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.